CTMX - Cytomx Therapeutics, Inc.

Name: Cytomx Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Sean A. McCarthy	1.08M	$2.35M	-
VP	Marcia Belvin	300.8K	$655.7K	-
CFO	Christopher Ogden	295.3K	$643.8K	-
Other	Yu-Waye Chu	189.4K	$413.0K	-
Other	Alejandra Carvajal	100.0K	$218.0K	-

Activity

Buys and sells only

Transactions

10 filings · page 14

Date	Insider	Role	Type	Shares	Price	Value	Chg%
Jun 1, 2016	Canaan IX L.P.	Director, 10% Owner	Sell	22,463	$10.75	$241,477.25	-0.5%
Jun 1, 2016	Timothy M Shannon82	Director	Sell	22,463	$10.75	$241,477.25	-0.5%
May 27, 2016	Canaan IX L.P.	Director, 10% Owner	Sell	25,082	$10.60	$265,869.20	-0.6%
May 27, 2016	Timothy M Shannon82	Director	Sell	25,082	$10.60	$265,869.20	-0.6%
May 26, 2016	Canaan IX L.P.	Director, 10% Owner	Sell	51,343	$10.34	$530,810.53	-1.1%
May 26, 2016	Timothy M Shannon82	Director	Sell	51,343	$10.34	$530,810.53	-1.1%
May 24, 2016	Timothy M Shannon82	-	Sell	13,253	$10.09	$133,735.30	-0.3%
May 24, 2016	Canaan IX L.P.	Director, 10% Owner	Sell	13,253	$10.09	$133,735.30	-0.3%
May 20, 2016	Canaan IX L.P.	Director, 10% Owner	Sell	8,687	$10.10	$87,776.83	-0.2%
May 20, 2016	Timothy M Shannon82	-	Sell	8,687	$10.10	$87,776.83	-0.2%

Understand these filings

How to Read SEC Form 4 Filings →Understanding Insider Buying Signals →What is Insider Trading? A Complete Guide →Cluster Buying: When Multiple Insiders Buy Together →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC